ArticleActa pharmaceutica Sinica. B2023

A novel mesenchymal stem cell-based regimen for acute myeloid leukemia differentiation therapy.

Luchen Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.